SCREENING
- American Heart Association
Summary of Recommendations - Screening Men
- Population
- Men 35 and Older
- The USPSTF strongly recommends screening men aged 35 and older for lipid disorders.
- Grade: A
- Men 20-35 at Increased Risk for CHD
- The USPSTF recommends screening men aged 20-35 for lipid disorders if they are at increased risk for coronary heart disease.
- Grade: B
- Men 35 and Older
Summary of Recommendations - Screening Women at Increased Risk
- Population
- Women 45 and Older at Increased Risk for CHD
- The USPSTF strongly recommends screening women aged 45 and older for lipid disorders if they are at increased risk for coronary heart disease.
- Grade: A
- Women 20-45 at Increased Risk for CHD
- The USPSTF recommends screening women aged 20-45 for lipid disorders if they are at increased risk for coronary heart disease.
- Grade: B
- Women 45 and Older at Increased Risk for CHD
U.S. Preventive Services Task Force
-
The USPSTF strongly recommends that clinicians routinely screen men 35 years and older and women 45 years and older for lipid disorders and treat abnormal lipid levels in persons who are at increased risk of coronary heart disease (A recommendation).
-
The USPSTF recommends screening men 20 to 35 years of age for lipid disorders if they are at increased risk of coronary heart disease (CHD). B recommendation.
-
The USPSTF recommends screening women 20 to 45 years of age for lipid disorders if they are at increased risk of CHD. B recommendation.
Children
- If has FHX either early ASCVD or significant Hypercholesterolemia, you may start screening from age 2 y.
- If found moderate to severe Hypercholesterolemia: screen first and second-degree relatives.
U.S. Preventive Services Task Force
- Timing of Screening
- The optimal interval for screening is uncertain. Reasonable options include every 5 years, shorter intervals for people who have lipid levels close to those warranting therapy, and longer intervals for those not at increased risk who have had repeatedly normal lipid levels.
- An age at which to stop screening has not been established. Screening may be appropriate in older people who have never been screened; repeated screening is less important in older people because lipid levels are less likely to increase after age 65 years.